Camp4 Therapeutics (CAMP) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 11, 2025, with voting available online or virtually until June 10, 2025.

• Shareholders are encouraged to review proxy materials and annual report before voting.

Voting matters and shareholder proposals

• Election of four Class I director nominees for three-year terms ending at the 2028 annual meeting.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.

• Proxies may vote on other business arising at the meeting or any adjournment.

Board of directors and corporate governance

• Nominees for Class I directors are James Boylan, Amir Nashat, ScD, Andrew J. Schwab, and Douglas Williams, PhD.